
Zilebesiran shows promising results in reducing systolic blood pressure in patients with hypertension.


coremsg

The investigational siRNA therapeutic showed consistent and sustained reductions in systolic blood pressure in a phase 2 study of adults with hypertension.

Positive Topline Results for Antihypertensive Zilebesiran

positive-results-for-zilebesiran-in-hypertension-treatment-study


Positive Results for Zilebesiran in Hypertension Treatment Study
